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CASE SERIES
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BACKGROUND: Optimal management of recurrent neurogenic thoracic outlet syndrome
(NTOS) remains a considerable challenge.
OBJECTIVE: To assess the safety and effectiveness of reoperative brachial plexus neurolysis in patients with recurrent NTOS.
METHODS: From 2009 to 2019, 85 patients underwent reoperative supraclavicular brachial
plexus neurolysis for recurrent NTOS after a previous anatomically complete supraclavicular
decompression. Data from a prospectively maintained database were analyzed retrospectively.
RESULTS: The mean patient age at reoperation was 36.9 ± 1.3 (range 15-64) years, 75%
were female, and the interval after previous primary operation was 2.5 ± 0.2 years. Intervening injury had precipitated recurrent NTOS in 14 patients (16%), and the mean
Disability of the Arm, Shoulder, and Hand (QuickDASH) score before reoperation was
65.2 ± 2.6, reﬂecting substantial disability. Operative ﬁndings consisted of dense ﬁbrous
scar tissue surrounding/encasing the brachial plexus. Compared with the previous primary operations, reoperations had a shorter operative time (198 ± 4 vs 161 ± 5 minutes,
P < .01) and hospital stay (4.4 ± 0.2 vs 3.6 ± 0.1 days, P < .01), but there were no signiﬁcant
differences in the frequency of prolonged hospitalization (7.1% vs 4.7%), early reoperation
(3.5% vs 1.2%), or 30-day hospital readmission (8.2% vs 7.1%). During a median follow-up
of 4.8 years, QuickDASH scores improved by 23.3 ± 2.6 (34.2% ± 3.6%; P < .01) and patientrated outcomes were excellent in 24%, good in 42%, fair in 26%, and poor in 8%.
CONCLUSION: Reoperative supraclavicular brachial plexus neurolysis is technically
challenging but safe and effective treatment for recurrent NTOS, with signiﬁcant improvements in symptoms and function. Diminishing perineural scar tissue development
and avoiding secondary injury would likely decrease the need for reoperations.
KEY WORDS: Brachial plexus, Case series, Compression neuropathy, Nerve wrapping, Patient-reported outcomes
measures, Reoperation, Thoracic outlet syndrome
Operative Neurosurgery 23:125–132, 2022

N

eurogenic thoracic outlet syndrome
(NTOS) is an uncommon condition
caused by dynamic compression of the

ABBREVIATIONS: ATOS, arterial thoracic outlet syndrome;
BP, brachial plexus; EAST, elevated arm stress test; F/U,
follow-up; NTOS, neurogenic thoracic outlet syndrome;
QuickDASH, 11-item disability of the arm, shoulder,
and hand survey instrument; SC, supraclavicular; SVS,
Society for Vascular Surgery; TOS, thoracic outlet
syndrome; VTOS, venous thoracic outlet syndrome.
Operative Neurosurgery Speaks! Audio abstracts available
for this article at operativeneurosurgery-online.com. Audio
abstracts can be located under “Associated Multimedia.”
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brachial plexus.1-8 NTOS arises because of
predisposing variations in anatomy and neck or
upper extremity injury, with diagnosis requiring exclusion of other conditions and
speciﬁc clinical criteria.9-12 Physical therapy
and pain management can improve symptoms
in many patients with NTOS, but surgical
treatment is recommended for those with
disabling symptoms and failure to improve
with conservative measures.11-14 Surgical decompression can be safely conducted through
transaxillary, supraclavicular, or posterior approaches, with excellent early results and sustained outcomes.15-25
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Despite effective surgical treatment for NTOS, approximately
5% to 30% of patients experience minimal improvement or
symptom recurrence during long-term follow-up.26-40 Incomplete operations and perineural scar tissue have been implicated in
the development of recurrent NTOS.26-40 Reoperations involving
resection of residual scalene muscles and ﬁrst rib remnants can be
safe and effective, as demonstrated in a recent study from our
medical center.40 However, it is less clear how to optimally address patients who have previously undergone an anatomically
complete decompression in which the scalene muscles and ﬁrst rib
have already been removed. The purpose of this study was to assess
clinical characteristics and long-term results in a more homogeneous population of patients who underwent reoperative brachial
plexus neurolysis after a previous anatomically complete supraclavicular decompression for NTOS.

METHODS
Derivation of the Study Population
The study population was derived from patients treated at our institution between June 2009 and April 2019. Patients with arterial or
venous TOS were excluded, as were patients with neurogenic symptoms
combined with either of the vascular forms of TOS, in accord with
Society for Vascular Surgery (SVS) reporting standards.9-12
During the study interval, 1561 patients underwent surgical treatment
for NTOS, of which 238 (15%) were reoperative procedures (Figure 1).
Reoperative procedures conducted after previous operations at other
institutions (n = 90) were excluded as the subjects of a recently published
study.40 There were 106 supraclavicular reoperations performed after a
previous anatomically complete primary operation conducted at our
institution, with 21 representing multiple or other reoperations, leaving
85 patients to constitute the study population for this report. All these
patients had undergone a previous anatomically complete primary operation consisting of supraclavicular anterior and middle scalenectomy,
ﬁrst rib resection, and complete brachial plexus neurolysis, with or
without adjunctive pectoralis minor tenotomy.
Detailed information regarding each patient was obtained from a prospectively maintained database and summarized from ofﬁce notes, hospital
charts, imaging studies, operative ﬁndings, and records from treating
physicians and therapists. This study was approved by the Institutional
Review Board at our medical center, with all patients providing written
informed consent to study participation. This case series has been reported in
line with the Preferred Reporting of Case Series in Surgery Guidelines.41

Clinical Diagnosis, Disability, and Initial Treatment
Each patient met clinical diagnostic criteria for NTOS as developed by
the Consortium for Outcomes Research and Education on Thoracic
Outlet Syndrome and the SVS reporting standards.9-12 Presenting
symptoms typically consisted of pain, numbness, and paresthesia affecting the neck and upper extremity, with characteristic physical examination ﬁndings of localizing tenderness and reproduction of upper
extremity symptoms on palpation over the supraclavicular space and
during provocative maneuvers. The level of functional disability was
assessed using the 11-item version of the Disabilities of the Arm,
Shoulder, and Hand (QuickDASH) survey instrument, which has been
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validated for various upper extremity disorders including NTOS.11,14,40
All patients underwent initial conservative treatment with NTOS-speciﬁc
physical therapy and pain management approaches.14,42

Surgical Treatment
Reoperative surgical treatment was offered to patients with a sound
clinical diagnosis of recurrent NTOS, signiﬁcant functional disability,
and insufﬁcient symptom improvement with physical therapy and pain
management.14,19,24,40 Throughout the study period, this consisted of
supraclavicular re-exploration by a single senior surgeon, with complete
external neurolysis of all 5 nerve roots and 3 trunks of the brachial
plexus.24 In many patients, adjunctive subcoracoid re-exploration with
brachial plexus neurolysis was also performed through a separate deltopectoral groove incision, including pectoralis minor tenotomy if not
performed previously.25 These operations thereby differed from the
reoperations performed in our previously published study in which the
procedures involved resection of residual scalene muscles and ﬁrst rib
remnants.40 At the end of the procedure, the supraclavicular brachial
plexus was wrapped with the same absorbable polylactide ﬁlm used in
primary operations (off-label use of SurgiWrap Bioresorbable Sheet,
MAST Biosurgery USA, Inc) to promote nerve mobility and diminish the
potential for perineural adhesions. Postoperative complications, hospital
stay, and readmissions were all recorded in the prospective database.

Follow-up and Outcomes Measures
As previously described, patients resumed physical therapy 3 to
4 weeks after reoperation and were seen for ofﬁce visits at least every 3 to
4 months after the initial recovery from surgery.40 At each visit, patients
completed the QuickDASH survey and were asked to rate their outcome
of treatment on a simple scale using one of the following descriptors:
“excellent” (relief of almost all major symptoms with only some mild
residual symptoms that do not signiﬁcantly limit enjoyment of life),
“good” (relief of most major symptoms with some mild residual
symptoms that signiﬁcantly limit enjoyment of life), “fair” (partial relief of
some symptoms, whereas other major symptoms persist), or “poor” (not
enough relief in symptoms to have made the operation worthwhile).

Statistical Analysis
The principal outcome measure was the percent improvement in the
QuickDASH score between initial preoperative evaluation and the
longest interval of follow-up. Descriptive data are presented as mean ± SE,
median and range, or the frequency (percent incidence). For two-group
comparisons, Fisher’s exact test or the unpaired student t-test with twotailed distribution was used to determine statistical signiﬁcance. All
statistical tests were performed using Prism version 6.0h (GraphPad
Software, Inc), with P values <.05 considered signiﬁcant.

RESULTS
Presenting Characteristics
The study population consisted of 64 women (75%) and 21
men (25%) with a mean age of 36.9 ± 1.3 (median 37, range 1564) years at the time of reoperation (Table 1). The age distribution
included 9 patients (11%) younger than age 21 years and 76
(89%) older than age 21 years (Figure 2A). The mean interval
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FIGURE 1. Derivation of the study population. Pie chart showing the proportion of patients undergoing surgical treatment for NTOS,
ATOS, and VTOS during the study period, with the vertical bar illustrating the number of primary and reoperative procedures for NTOS.
The study population for this investigation was composed of 85 patients having SC reoperations with BP neurolysis for recurrent NTOS,
after a previous anatomically complete primary operation at our institution. ATOS, arterial thoracic outlet syndrome; BP, brachial plexus;
NTOS, neurogenic thoracic outlet syndrome; SC, supraclavicular; VTOS, venous thoracic outlet syndrome. Adapted with permission by
STM agreement from Jammeh ML, Ohman JW, Vemuri C et al, “Anatomically complete supraclavicular reoperation for recurrent
neurogenic thoracic outlet syndrome: clinical characteristics, operative ﬁndings, and long-term outcomes,” Hand (NY), published online
ahead of print: January 27, 2021, doi: 10.1177/1558944720988079.40

between the previous primary operation and reoperation was
30.0 ± 2.6 months (median 22.2 months, range 4-135 months),
with 59% developing recurrent NTOS within 2 years and 89%
within 5 years (Figure 2B). Of the 85 patients undergoing reoperation, 67 underwent the previous primary operation during
the period encompassed by this study (18 had the previous
primary operation before June 2009). During the same time
interval, there were 1202 patients who underwent an anatomically
complete supraclavicular primary operation. The overall longterm recurrence rate for primary operations was thereby estimated
to be 5.6%.
Each patient met the Consortium for Outcomes Research and
Education on Thoracic Outlet Syndrome and SVS criteria for a
diagnosis of recurrent NTOS.9-12 The mean duration of the 3minute Elevated Arm Stress Test was 73.9 ± 5.6 seconds, and the
mean QuickDASH score before reoperation was 65.2 ± 2.6, reﬂecting a substantial level of disability.11 Only 25 patients (29%)
were working full time at presentation, with 6 (7%) working part
time under restrictions and 36 (42%) being disabled or unemployed. There was a history of injury in 29 patients (34%)
before the previous primary operation and an intervening injury
that had precipitated recurrent NTOS in 14 patients (16.5%), at
a mean interval of 1.5 ± 0.3 years after the primary operation
(Table 2).
Surgical Treatment
All patients underwent supraclavicular re-exploration and
complete external neurolysis for ﬁbrous perineural scar tissue
surrounding/encasing the brachial plexus, typically with adherence to the scalene fat pad, extrapleural fascia, and bed of the
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previously resected ﬁrst rib. No patient was found to have residual
scalene muscle or a ﬁrst rib remnant. Most of the operations were
conducted solely with a supraclavicular approach, whereas 24
(28%) included a reoperative subcoracoid exploration with brachial plexus neurolysis and 10 (12%) included a primary pectoralis
minor tenotomy based on localizing tenderness at preoperative
examination. There were no intraoperative complications in the

TABLE 1. Presenting Characteristics of the Study Population
Demographics
Mean age at primary operation (y)
Mean age at reoperation (y)
Mean interval to reoperation (mo)
Female sex
Right side affected
Local metropolitan referral
Regional referral (<200 miles)
Distant referral (>200 miles)
Examination ﬁndings
3-min EAST (s)
QuickDASH score
Preoperative work status
Full time
Part time or restricted
Disabled or unemployed
Student
Retired

34.4 ± 1.3
36.9 ± 1.3
30.0 ± 2.6
64 (75.3%)
46 (54.1%)
21 (24.7%)
38 (44.7%)
26 (30.1%)
73.9 ± 5.6
65.2 ± 2.60
25 (29.4%)
6 (7.1%)
36 (42.3%)
17 (20.0%)
1 (1.2%)

EAST, elevated arm stress test; QuickDASH, 11-item version of the disabilities of the
arm, shoulder, and hand.
Data shown indicate the number of patients (%) for categorical variables or the mean ±
SE for continuous measures.
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FIGURE 2. Distribution of the study population. A, Age distribution of patients in the study population. B, Distribution of
patients according to the interval between the previous operation and reoperation.

study population, including nerve injury. The overall duration of
supraclavicular reoperation was 161 ± 5 minutes, which compared
favorably with the duration of the previous primary operation
(198 ± 4 minutes; P < .01) (Table 3). The hospital length of stay
after reoperations was 3.6 ± 0.1 days, which was also less than that
after the previous primary operation (4.4 ± 0.2 days; P = .01).
There were no signiﬁcant differences between reoperations and
the previous primary operations regarding other measures of
perioperative care, including the incidence of prolonged hospital
stay, early reoperations, or readmission to the hospital within
30 days of operation (Table 3).
Follow-up and Outcomes
The mean duration of clinical follow-up after reoperations was
5.5 ± 0.3 years (Table 4). The mean QuickDASH score at followup was 37.6 ± 2.8, and for individual patients, the mean decline in
the QuickDASH score was 23.3 ± 2.6 (34.2% ± 3.6%), reﬂecting a
signiﬁcant improvement compared with preoperative QuickDASH
scores (P < .01). There were no differences between reoperations
and the previous primary operations regarding preoperative
QuickDASH scores, postoperative follow-up QuickDASH scores,
or the extent of decline in QuickDASH scores although the percent
improvement in QuickDASH scores was somewhat less after
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reoperations when compared with the previous primary operations
(34.2% ± 3.6% vs 45.1% ± 3.1%; P = .02).
Patient-rated outcomes corresponded with the outcomes
measured by changes in QuickDASH scores, after both primary

TABLE 2. Prevalence of Previous and Intervening Injuries in the
Study Population
History of previous injury before primary operation
None
Motor vehicle collision
Work-related
Sports-related
Fall on the arm
All types
History of intervening injury after primary operation
None
Motor vehicle collision
Work-related
Sports-related
Fall on the arm
All types

56
9
4
5
11
29

(65.9%)
(10.6%)
(4.7%)
(5.9%)
(12.9%)
(34.1%)

71
4
0
5
5
14

(83.5%)
(4.7%)
(0%)
(5.9%)
(5.9%)
(16.5%)

Data shown indicate the number of patients (%).
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TABLE 3. Perioperative Care, Previous Primary Operations vs Reoperations
Outcome Measures
Duration of operation (min)
Hospital length of stay (d)
Prolonged hospital stay (>6 d)
Early reoperation
30-day readmission

Previous primary operation

Reoperation

P value

198 ± 4
4.4 ± 0.2
6 (7.1%)b
3 (3.5%)e
7 (8.2%)g

161 ± 5
3.6 ± 0.1
4 (4.7%)c
1 (1.2%)f
6 (7.1%)h

<.01a
.01a
.75d
.62d
>.99d

Unpaired t-test.
Lymph leak (n = 5) and pain control (n = 1).
c
Pain control (n = 2), wound hematoma (n = 1), and prolonged nausea/vomiting (n = 1).
d
Fisher’s exact test.
e
Operative control of lymph leak (n = 3).
f
Wound re-exploration for hematoma (n = 1).
g
Pain control (n = 3), dehydration (n = 1), pancreatitis (n = 1), lymph leak (n = 1), and wound infection and pleural effusion (n = 1).
h
Pain control (n = 5) and wound infection (n = 1).
Data shown indicate the mean ± SE for continuous measures or the number and percent of patients for categorical variables.
a

b

operations and reoperations (Figure 3A and 3B). The proportion
of patients with outcomes rated as excellent was less after reoperations than after the previous primary operations, the proportion with outcomes rated as good was equivalent, and the
proportion with outcomes rated as fair was greater after reoperations (Figure 3C). During long-term follow-up after reoperation,
11 patients (12.9%) later underwent a third supraclavicular operation for re-recurrent symptoms, a recurrence rate higher than
the 5.6% observed for primary operations (P = .02).

DISCUSSION
Key Results in the Context of Relevant Literature
Although reported outcomes are excellent for contemporary
surgical treatment of NTOS, up to 30% of patients can be expected to have persistent symptoms or to develop later recurrence.26-40 In a previously published study, we reported excellent
outcomes for reoperations that were performed for recurrent
NTOS after procedures performed at other institutions, in which
the operative ﬁndings frequently included residual scalene muscle
and ﬁrst rib remnants.40 In this study, we assessed the separate and
more homogeneous population of patients with recurrent NTOS

who had previously undergone anatomically complete supraclavicular decompression at our institution, in which the reoperative procedure consisted solely of brachial plexus neurolysis.
The initial success of the previous primary operations was
reﬂected by a mean improvement in QuickDASH scores of 27.6 ±
2.0 (45.1% ± 3.1%) with 74 of 85 patients (87%) rating their
outcomes as good or excellent. We estimated the recurrence rate
after previous primary operations to be 5.6%, which compares
favorably with other studies.26-40 We also found that the mean
time interval from the previous primary operation to reoperation
for recurrence was approximately 2.5 years. These observations
reinforce that long-term follow-up and careful assessment of
recurrent symptoms are needed in all patients who have undergone surgical treatment for NTOS. It is notable that the incidence
of recurrent NTOS is often not described in studies focused on
short-term and mid-term results of surgery and those solely using
patient-reported outcomes measures and that deﬁning recurrence
rates requires follow-up for at least several years.32,33,38,40 The low
recurrence rate for primary operations deﬁned in this study
thereby serves as a useful benchmark for future investigations.
This study differs from previous reports because the reoperations described here did not involve structural anatomic factors
responsible for recurrent nerve compression, removal of residual

TABLE 4. Comparison of Outcomes, Previous Primary Operations vs Reoperations
Outcome Measures
Initial QuickDASH score
F/U QuickDASH score
Initial vs F/U QuickDASH score
F/U decline in QuickDASH score
F/U %decline in QuickDASH score

Previous primary operation

Reoperation

P value

60.0 ± 2.0
33.6 ± 2.1
P < .01a
27.6 ± 2.0
45.1 ± 3.1

65.2 ± 2.0
37.6 ± 2.8
P < .01a
23.3 ± 2.6
34.2 ± 3.6

.06a
.26a
.19a
.02a

F/U, follow-up; QuickDASH, 11-item disability of the arm, shoulder, and hand survey instrument.
a
Paired t-test.
The mean duration of F/U after reoperations was 5.5 ± 0.3 years (median, 4.8 years; range 1.3-11.1 years). Data shown indicate the mean ± SE.

OPERATIVE NEUROSURGERY

VOLUME 23 | NUMBER 2 | AUGUST 2022 | 129

JAMMEH ET AL

FIGURE 3. Outcomes measures for patients undergoing supraclavicular reoperation for NTOS. A, Bar graph comparing the percent improvement in
QuickDASH scores for different patient-reported outcomes for patients undergoing previous primary operation for NTOS. B, Bar graph comparing the
percent improvement in QuickDASH scores for different patient-reported
outcomes for patients undergoing supraclavicular reoperation for recurrent
NTOS. C, Bar graphs illustrating the proportion of patients in each patientreported outcomes category after previous primary operations and reoperations
for NTOS. Paired comparisons were made using Fisher’s exact test. NTOS,
neurogenic thoracic outlet syndrome; QuickDASH, 11-item Disability of the
arm, shoulder, and hand survey instrument.

(reattached) scalene muscle, or resection of any retained/residual ﬁrst
rib.40 Rather, the cause of recurrent NTOS in the patients evaluated
in this study was solely attributable to ﬁbrous perineural scar tissue
that had developed during follow-up. Reoperative supraclavicular
exploration and brachial plexus neurolysis require meticulous careful
dissection to avoid nerve and vascular injury, but the perioperative
outcomes in this series, including low early complication rates, did
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not seem to be inﬂuenced by the previous operation. Both the
average operative time and hospital stay were also lower after reoperations than primary operations. These ﬁndings demonstrate that
supraclavicular reoperation is a viable option for patients with disabling recurrent symptoms, even when no speciﬁc structural deﬁcit is
apparent relative to the previous procedure(s).
This study highlights that prevention of recurrent NTOS is an
elusive goal, even after anatomically complete thoracic outlet
decompression. We found an intervening secondary injury to be
documented in 16% of the patients in this series, but this is likely
an underappreciated factor in stimulating perineural ﬁbrosis. In
many patients, progressive increases in activity over time may also
result in exacerbations of symptoms that may subsequently
progress into full recurrence. Early suspicion of recurrence is
valuable toward instigating conservative treatment measures that
may forestall the need for reoperation.
Another factor that could limit the potential for recurrence is
the use of external nerve wrapping as a physical barrier to prevent
perineural scar that might otherwise compress, tether, and irritate
the brachial plexus. There are precedents for this strategy in the
treatment of recurrent ulnar neuropathy and carpal tunnel syndrome and in spine operations, as well as in NTOS, using a
spectrum of different biocompatible materials (eg, polymeric
ﬁlms, carbohydrate gels, collagen matrix, amniotic membrane,
and autologous vein).43-46 Throughout the course of this study, it
was our regular practice to wrap the supraclavicular brachial plexus
with a bioabsorbable polylactide ﬁlm expected to dissolve within 3
to 4 months. It is possible that after primary operations, patients
might have become more susceptible to development and accumulation of perineural scar after absorption of this barrier,
especially in the context of increasing activity or secondary injury.
Anecdotal use of the human amniotic membrane to wrap the
brachial plexus suggests that this material might have advantages
as a more durable biological extracellular matrix to suppress
perineural ﬁbrosis, but this is yet to be thoroughly evaluated.47
Long-term outcomes in this study, as assessed by clinical
improvement in symptoms and changes in QuickDASH scores,
were satisfactory in nearly 90% of patients. Although the results in
this patient population were comparable with those undergoing
primary supraclavicular decompression for NTOS, the extent of
improvement after reoperations (measured by QuickDASH
scores) was not as great as that observed after primary operations.
The overall rate of re-recurrence after reoperation for NTOS in
our population was 12.9%, which is higher than the 5.6% recurrence rate for patients undergoing primary surgical decompression. This underscores the need for long-term follow-up,
ongoing clinical assessment, and prompt consideration for reoperation when appropriate.
Strengths, Limitations, and Directions for
Future Research
The main strengths of this study are that all patients underwent
a standardized treatment strategy with favorable and sustained
outcomes and that all patients were followed with quantitative
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outcomes measures to allow more accurate comparisons between
groups and over time. One of the limitations of this study is that
we are unable to be certain if, during long-term follow-up after
reoperation, some patients might have had recurrent symptoms or
secondary operations elsewhere after our last recorded ofﬁce visit.
We feel that this is unlikely given that most of the patients in this
series continued long-term follow-up with our center. Another
limitation is that we do not have more detailed data on the time
course and trajectory of recurrent symptoms after primary operations, which would be a valuable direction for future research.
Because the basis for this study was the identiﬁed population of
patients who had undergone reoperations for recurrent NTOS,
we were unable to more comprehensively analyze factors that
might have contributed to recurrence after primary operations.
We were also unable to assess nonoperative methods of treatment
for recurrent symptoms that might have been successful in
avoiding the need for surgery. These important questions would
have to be addressed more speciﬁcally in a prospectively designed
study. Finally, it remains important to reiterate that reoperations
for NTOS are technically challenging and likely to carry greater
risks for nerve and/or vascular injury than primary operations,
because of the extensive scarring encountered and distortions in
anatomy. These procedures should therefore be undertaken only
by surgeons with considerable experience with brachial plexus
surgery and operations for NTOS.

CONCLUSION
For carefully selected patients with recurrent NTOS despite a
previous anatomically complete decompression, reoperative supraclavicular brachial plexus neurolysis is technically challenging
but safe and effective. Long-term outcomes show that supraclavicular reoperations can achieve signiﬁcant symptom reduction
and functional improvement for approximately 90% of patients
with recurrent NTOS. Diminishing the development of perineural scar tissue and avoiding secondary injury during follow-up
would likely decrease the need for reoperative interventions.
Funding
This work was supported in part by the Thoracic Outlet Syndrome Research
and Education Fund of the Foundation for Barnes Jewish Hospital, BJC
Healthcare, St. Louis, Missouri. The Foundation for Barnes Jewish Hospital had
no involvement in the study design, collection, analysis, and interpretation of the
data; manuscript writing; or the decision to submit the manuscript for publication.

Disclosures
The authors have no personal, ﬁnancial, or institutional interest in any of the
drugs, materials, or devices described in this article.

REFERENCES
1. Sheth RN, Belzberg AJ. Diagnosis and treatment of thoracic outlet syndrome.
Neurosurg Clin N Am. 2001;12(2):295-309.
2. Mackinnon SE, Novak CB. Thoracic outlet syndrome. Curr Probl Surg. 2002;
39(11):1070-1145.

OPERATIVE NEUROSURGERY

3. Toussaint CP, Zager EL. Thoracic outlet syndrome. In: Youmans JR, Winn HR,
eds. Youmans Neurological Surgery. 6th ed. Elsevier; 2011:2440-2446.
4. Kuhn JE, Lebus V GF, Bible JE. Thoracic outlet syndrome. J Am Acad Orthop Surg.
2015;23(4):222-232.
5. Thompson RW. Thoracic outlet syndrome: neurogenic. In: Sidawy AN, Perler BA,
eds. Rutherford’s Vascular Surgery and Endovascular Therapy. 9th ed. Elsevier; 2018:
1619-1638.
6. Jones MR, Prabhakar A, Viswanath O, et al. Thoracic outlet syndrome: a comprehensive review of pathophysiology, diagnosis, and treatment. Pain Ther. 2019;
8(1):5-18.
7. Li N, Dierks G, Vervaeke HE, et al. Thoracic outlet syndrome: a narrative review.
J Clin Med. 2021;10(5):962.
8. DiLosa KL, Humphries MD. Epidemiology of thoracic outlet syndrome. Semin
Vasc Surg. 2021;34(1):65-70.
9. Illig KA, Donahue D, Duncan A, et al. Reporting standards of the Society for
Vascular Surgery for thoracic outlet syndrome. J Vasc Surg. 2016;64(3):
e23-e35.
10. Thompson RW. Diagnosis of neurogenic thoracic outlet syndrome: 2016 consensus guidelines and other strategies. In: Illig KA, Thompson RW, Freischlag JA,
et al, eds. Thoracic Outlet Syndrome. 2nd ed. Springer Nature; 2021:67-97.
11. Balderman J, Holzem K, Field BJ, et al. Associations between clinical diagnostic
criteria and pretreatment patient-reported outcomes measures in a prospective
observational cohort of patients with neurogenic thoracic outlet syndrome. J Vasc
Surg. 2017;66(2):533.e2-544.e2.
12. Pesser N, Goeteyn J, van der Sanden L, et al. Feasibility and outcomes of a
multidisciplinary care pathway for neurogenic thoracic outlet syndrome: a prospective observational cohort study. Eur J Vasc Endovasc Surg. 2021;61(6):
1017-1024.
13. Povlsen B, Belzberg A, Hansson T, Dorsi M. Treatment for thoracic outlet
syndrome. Cochrane Database Syst Rev. 2010;(1):CD007218.
14. Balderman J, Abuirqeba AA, Eichaker L, et al. Physical therapy management,
surgical treatment, and patient-reported outcomes measures in a prospective observational cohort of patients with neurogenic thoracic outlet syndrome. J Vasc
Surg. 2019;70(3):832-841.
15. Dubuisson AS, Kline DG, Weinshel SS. Posterior subscapular approach to the
brachial plexus. Report of 102 patients. J Neurosurg. 1993;79(3):319-330.
16. Urschel HC Jr, Razzuk MA. Neurovascular compression in the thoracic outlet:
changing management over 50 years. Ann Surg. 1998;228(4):609-617.
17. Sheth RN, Campbell JN. Surgical treatment of thoracic outlet syndrome: a randomized trial comparing two operations. J Neurosurg Spine. 2005;3(5):355-363.
18. Tender GC, Kline DG. Anterior supraclavicular approach to the brachial plexus.
Neurosurgery. 2006;58(4 suppl 2):ONS-360-ONS-364.
19. Caputo FJ, Wittenberg AM, Vemuri C, et al. Supraclavicular decompression for
neurogenic thoracic outlet syndrome in adolescent and adult populations. J Vasc
Surg. 2013;57(1):149-157.
20. Orlando MS, Likes KC, Mirza S, et al. A decade of excellent outcomes after surgical
intervention in 538 patients with thoracic outlet syndrome. J Am Coll Surg. 2015;
220(5):934-939.
21. Hong J, Pisapia JM, Ali ZS, et al. Long-term outcomes after surgical treatment of
pediatric neurogenic thoracic outlet syndrome. J Neurosurg Pediatr. 2018;21(1):
54-64.
22. Jayaraj A, Duncan AA, Kalra M, Bower TC, Gloviczki P. Outcomes of transaxillary
approach to cervical and ﬁrst-rib resection for neurogenic thoracic outlet syndrome.
Ann Vasc Surg. 2018;51:147-149.
23. Ransom EF, Minton HL, Young BL, et al. Intermediate and long-term outcomes
following surgical decompression of neurogenic thoracic outlet syndrome in an
adolescent patient population. Hand (NY). 2022;17(1):43-49.
24. Thompson RW, Ohman JW. Surgical techniques: operative decompression using
the supraclavicular approach for neurogenic thoracic outlet syndrome. In: Illig KA,
Thompson RW, Freischlag JA, et al, eds. Thoracic Outlet Syndrome. 2nd ed.
Springer Nature; 2021:265-285.
25. Vemuri C, Thompson RW. Surgical techniques: pectoralis minor tenotomy for
neurogenic thoracic outlet syndrome. In: Illig KA, Thompson RW, Freischlag
JA, et al, eds. Thoracic Outlet Syndrome. 2nd ed. Springer Nature; 2021:295-301.
26. Urschel HC Jr, Razzuk MA, Albers JE, et al. Reoperation for recurrent thoracic
outlet syndrome. Ann Thorac Surg. 1976;21(1):19-25.
27. Roos DB. Recurrent thoracic outlet syndrome after ﬁrst rib resection. Acta Chir
Belg. 1980;79(5):363-372.

VOLUME 23 | NUMBER 2 | AUGUST 2022 | 131

JAMMEH ET AL

28. Sessions RT. Reoperation for thoracic outlet syndrome. J Cardiovasc Surg (Torino).
1989;30(3):434-444.
29. Sanders RJ, Haug CE, Pearce WH. Recurrent thoracic outlet syndrome. J Vasc
Surg. 1990;12(4):390-400.
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COMMENT

I

n virtually all articles on treating TOS, there are patients included who
are revisions of previously performed TOS procedures. It is usually the
authors’ opinion that various technical factors that differ from the authors’ preferred method of treatment are the cause of the failure. These
include failing to resect the rib or enough of it, failure to resect muscle or
enough, etc. Although the authors’ primary premise is that revision can be
safe and effective, by far, the most important premise and ﬁnding is that
recurrences will occur in the face of complete resection of everything
touching the nerves. This has been known and understood by peripheral
nerve surgeons and perhaps will now be understood by those performing
TOS procedures, which after all, are decompression of peripheral nerves.
This should be the primary goal of the procedure regardless of the
subspecialty of the surgeon. Decompression of arteries and veins is largely
secondary, and much more effort needs to be put into preventing recurrent scarring of the nerves.
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